App and coach aim to cut diabetes risk in pregnancy
NCT ID NCT07189221
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This European study tests a program called B2B&ME+ that uses a smartphone app and personal health coaching to help pregnant women at high risk for gestational diabetes. 3600 women will be enrolled across four countries. The goal is to see if this approach can reduce diabetes and improve health for mothers and babies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lifestyle intervention (smartphone app with Bluetooth scale and health coaching)
- What this could lead to
- If successful, this could provide a practical way to prevent gestational diabetes and improve long-term health for mothers and babies.
- What could go wrong
- This is an implementation study, not a drug trial. Results depend on how well women follow the program, and benefits may vary across countries and healthcare systems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS (GDM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden toll of gestational diabetes: study probes emotional and social impact
- Community-Driven strategies aim to end intergenerational type 2 diabetes in indigenous children
- Could a simple supplement help manage gestational diabetes?
- Could a daily glass of kefir during pregnancy ward off gestational diabetes?
- Hormonal clues may unlock better detection of pregnancy diabetes
- Could cocoa and veggies protect against pregnancy complications?